1-8 of 8
Thomas Kocher
Close
Sort by
Journal Articles

Proteinkinase C-β Inhibitors Mitigate Microenvironment-Mediated Survival Of CLL Cells and Sensitise Malignant B Cells To Cytotoxic Drugs

Gloria Lutzny, Zhoulei Li, Madlen Oelsner, Jolanta Slawska, Thomas Kocher, MSc, Alexander Egle, Christian Peschel, Ulrich Keller, Ingo Ringshausen, M.D.
Journal: Blood
Blood (2013) 122 (21): 669.
https://doi.org/10.1182/blood.V122.21.669.669
Published: 2013
Journal Articles

FMC-7 Expression Identifies Phenotypically Atypical Chronic Lymphocytic Leukemia with Distinct Clinical and Molecular Genetic Features.

Prashanti Reddy, MD, Bashar Dabbas, MD, Maggie Gama, Thomas Kocher, Hong L. Drum, MD, Jesalyn Taylor, Yin Xu, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2478.
https://doi.org/10.1182/blood.V120.21.2478.2478
Published: 2012
Journal Articles

Protein Kinase C-β Dependent Activation of NF-κB in Stromal Cells Is Indispensable for the Survival of Chronic Lymphocytic Leukemia B-Cells in Vivo

Gloria Lutzny, Thomas Kocher, MSc, Martina Rudelius, Marc Schmidt-Supprian, Ludger Klein-Hitpass, Jan Dürig, Robert A.J. Oostendorp, PhD, Christian Peschel, MD, Alexander Egle, Ingo Ringshausen
Journal: Blood
Blood (2012) 120 (21): 314.
https://doi.org/10.1182/blood.V120.21.314.314
Published: 2012
Journal Articles

BIRC3 but Not BIRC2 mRNA Expression in Chronic Lymphocytic Leukemia Correlates with Disease Progression and Mediates Decreased Fludarabine Sensitivity in Vitro

Daniela Asslaber, PhD, Josefina D. Pinon Hofbauer, PhD, Nadja Zaborsky, PhD, Thomas Kocher, MSc, Tanja N. Hartmann, PhD, Richard Greil, MD, Alexander Egle, MD
Journal: Blood
Blood (2012) 120 (21): 563.
https://doi.org/10.1182/blood.V120.21.563.563
Published: 2012
Journal Articles

Clonal Diversity of the T Cell Repertoire Predicts Disease Progression in Chronic Lymphocytic Leukaemia

Claudia Holler, PhD, Nadja Zaborsky, PhD, Josefina Pinon Hofbauer, PhD, Thomas Kocher, Doris Trapin, Daniela Asslaber, PhD, Richard Greil, MD, Alexander Egle, MD
Journal: Blood
Blood (2011) 118 (21): 803.
https://doi.org/10.1182/blood.V118.21.803.803
Published: 2011
Journal Articles

Association of natural anti-platelet factor 4/heparin antibodies with periodontal disease

Andreas Greinacher, Birte Holtfreter, Krystin Krauel, Daniela Gätke, Claudia Weber, Till Ittermann, Sven Hammerschmidt, Thomas Kocher
Journal: Blood
Blood (2011) 118 (5): 1395–1401.
https://doi.org/10.1182/blood-2011-03-342857
Published: 2011
Includes: Supplemental data
Journal Articles

Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets

Uwe Rix, Oliver Hantschel, Gerhard Dürnberger, Lily L. Remsing Rix, Melanie Planyavsky, Nora V. Fernbach, Ines Kaupe, Keiryn L. Bennett, Peter Valent, Jacques Colinge, Thomas Köcher, Giulio Superti-Furga
Journal: Blood
Blood (2007) 110 (12): 4055–4063.
https://doi.org/10.1182/blood-2007-07-102061
Published: 2007
Includes: Supplemental data
Journal Articles

IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation

Melanie Antl, Marie-Luise von Brühl, Christina Eiglsperger, Matthias Werner, Ildiko Konrad, Thomas Kocher, Matthias Wilm, Franz Hofmann, Steffen Massberg, Jens Schlossmann
Journal: Blood
Blood (2006) 109 (2): 552–559.
https://doi.org/10.1182/blood-2005-10-026294
Published: 2006
Includes: Multimedia, Supplemental data